Table 2 |
|||||||||||
|
Efficacy parameters |
|||||||||||
|
Characteristic |
Baseline (n = 21) |
3 weeks (n = 21) |
P-value |
15 weeks (n = 14) |
P-value |
||||||
|
|
|||||||||||
|
6-minute walking distance, m |
|||||||||||
|
Mean change |
386 |
± |
121 |
425 |
± |
118 |
447 |
± |
139 |
||
|
64 |
± |
17 |
< 0.001a |
71 |
± |
35 |
0.003 |
||||
|
95% CI for the difference to baseline |
42 |
- |
85 |
48 |
- |
95 |
|||||
|
|
|||||||||||
|
Quality of life questionnaire SF36, score |
|||||||||||
|
Physical functioning |
33.5 |
± |
20 |
0.025b |
45.2 |
± |
20 |
0.025b |
|||
|
Role-physical |
60.4 |
± |
36 |
0.317 |
65.6 |
± |
23 |
0.317 |
|||
|
Bodily pain |
58.1 |
± |
33 |
0.260 |
62.2 |
± |
31 |
0.260 |
|||
|
General health perception |
31.6 |
± |
15 |
0.049b |
35.9 |
± |
14 |
0.049b |
|||
|
Vitality |
38.1 |
± |
14 |
0.021b |
48.1 |
± |
18 |
0.021b |
|||
|
Social functioning |
61.8 |
± |
30 |
0.008a |
71.4 |
± |
23 |
0.008a |
|||
|
Role-emotional |
77.6 |
± |
22 |
0.115 |
91.6 |
± |
14 |
0.115 |
|||
|
Mental Health |
56.8 |
± |
21 |
0.033b |
66.2 |
± |
16 |
0.033b |
|||
|
|
|||||||||||
|
Cardiopulmonary exercise testing |
|||||||||||
|
Peak VO2/kg, mL/min/kg |
11.8 |
± |
3.4 |
13.6 |
± |
3.4 |
0.010b |
14.1 |
± |
3.5 |
0.008a |
|
Peak VO2, ml/min |
822 |
± |
252 |
882 |
± |
218 |
0.011b |
887 |
± |
139 |
0.007a |
|
EqCO2 at AT, ml/min |
41.3 |
± |
8.9 |
41.3 |
± |
9.5 |
0.529 |
42.8 |
± |
7.1 |
0.138 |
|
VO2 at AT; ml/min |
619 |
± |
172 |
689 |
± |
207 |
0.013b |
681 |
± |
207 |
0.012b |
|
Oxygen pulse, (mL/min)/min-1 |
6.7 |
± |
1.6 |
6.8 |
± |
1.8 |
0.127 |
6.3 |
± |
0.4 |
0.260 |
|
HR rest, min-1 |
85 |
± |
14 |
77 |
± |
12 |
0.0001a |
78 |
± |
16 |
0.045b |
|
HR max, min-1 |
122 |
± |
21 |
127 |
± |
18 |
0.076 |
140 |
± |
20 |
0.005a |
|
RRsys rest, mmHg |
117 |
± |
17 |
114 |
± |
15 |
0.092 |
111 |
± |
15 |
0.653 |
|
RRdiast rest, mmHg |
75 |
± |
8 |
71 |
± |
9 |
0.038b |
72 |
± |
8 |
0.464 |
|
RRsys max, mmHg |
149 |
± |
28 |
154 |
± |
18 |
0.743 |
153 |
± |
18 |
0.002a |
|
RRdias max, mmHg |
85 |
± |
13 |
88 |
± |
14 |
0.292 |
88 |
± |
12 |
0.083 |
|
Oxygen saturation rest, % |
94.7 |
± |
3.0 |
96.7 |
± |
3.2 |
0.266 |
96.4 |
± |
2.8 |
0.421 |
|
Oxygen saturation max, % |
89.8 |
± |
5.6 |
90.8 |
± |
5.8 |
0.052 |
91.7 |
± |
6.3 |
0.018b |
|
sPAP rest, mmHg |
52 |
± |
14 |
47 |
± |
9 |
0.005a |
50 |
± |
10 |
0.210 |
|
sPAP max, mmHg |
85 |
± |
26 |
87 |
± |
20 |
0.959 |
89 |
± |
14 |
0.320 |
|
Workload max, W |
55 |
± |
19 |
67 |
± |
23 |
0.007a |
65 |
± |
20 |
0.008a |
|
Borg Scale, score |
16 |
± |
2 |
15 |
± |
2 |
0.171 |
15 |
± |
1 |
0.105 |
|
|
|||||||||||
|
Laboratory parameters |
|||||||||||
|
C-reactive protein, mg/l |
15.2 |
± |
22.5 |
8.3 |
± |
9.7 |
0.069 |
6.6 |
± |
5.3 |
0.071 |
|
Leucocytes, 109/l |
9.2 |
± |
7.5 |
10.0 |
± |
12.9 |
0.071 |
8.6 |
± |
7.6 |
0.177 |
|
NT-proBNP, pg/ml |
1928 |
± |
4623 |
1101 |
± |
1380 |
0.164 |
2321 |
± |
2671 |
0.646 |
|
|
|||||||||||
|
Values are mean ± standard deviation. aP < 0.01, bP < 0.05 in comparison to baseline; P-values are the same for absolute values and differences. 6-minute walking distance data were analyzed by the two-sided Student t-test; cardiopulmonary exercise testing data were analyzed by the Wilcoxon test. CI: confidence interval; SF-36: short-form Health Survey Questionnaire; VO2/kg: maximum oxygen consumption/kg; EqCO2: ventilatory equivalent for carbon dioxide; HR: heart rate; RRsys: systolic blood pressure; RRdiast: diastolic blood pressure; sPAP: systolic pulmonary arterial pressure; NT-proBNP: N-terminal prohormone of brain natriuretic peptide. |
|||||||||||
|
Grünig et al. Arthritis Research & Therapy 2012 14:R148 doi:10.1186/ar3883 |
|||||||||||